Effect of simvastatin on vascular tone in porcine coronary artery: Potential role of the mitochondria

Toxicology and Applied Pharmacology

Volumn 305, Issue , 2016, Pages 176-185

  Almukhtar, H ^a   Garle, M J ^a   Smith, P A ^a   Roberts, R E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Mitochondria; Statins; Vasodilatation

Indexed keywords

ANTIMYCIN A1; CALCIUM; DORSOMORPHIN; GLIBENCLAMIDE; MEVINOLIN; MYXOTHIAZOL; PRAVASTATIN; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; ROTENONE; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CONNECTIVE TISSUE; CONTROLLED STUDY; CORONARY ARTERY; HEART MITOCHONDRION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CORONARY BLOOD VESSEL; DRUG EFFECTS; FEMALE; IN VITRO STUDY; MALE; PHYSIOLOGY; PIG; VASODILATATION;

ANIMALS; CALCIUM; CORONARY VESSELS; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IN VITRO TECHNIQUES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MYOCYTES, SMOOTH MUSCLE; SIMVASTATIN; SWINE; VASODILATION;

EID: 84976285847     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2016.06.024     Document Type: Article

References (67)

1. Abdoli, N., Heidari, R., Azarmi, Y., Eghbal, M.A., Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J. Biochem. Mol. Toxicol. 27 (2013), 287–294.
2. Alvarez De Sotomayor, M., Herrera, M.D., Marhuenda, E., Andriantsitohaina, R., Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat. Br. J. Pharmacol. 131 (2000), 1179–1187.
3. Bergdahl, A., Persson, E., Hellstrand, P., Sward, K., Lovastatin induces relaxation and inhibits L-type Ca(2 +) current in the rat basilar artery. Pharmacol. Toxicol. 93 (2003), 128–134.
4. Bubolz, A.H., Mendoza, S.A., Zheng, X., Zinkevich, N.S., Li, R., Gutterman, D.D., Zhang, D.X., Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2 + entry and mitochondrial ROS signaling. Am. J. Physiol. Heart Circ. Physiol. 302 (2012), H634–H642.
5. Buyukafsar, K., Nelli, S., Martin, W., Formation of nitric oxide from nitroxyl anion: role of quinones and ferricytochrome c. Br. J. Pharmacol. 132 (2001), 165–172.
6. Carreras, M.C., Franco, M.C., Peralta, J.G., Poderoso, J.J., Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Mol. Asp. Med. 25 (2004), 125–139.
7. Chalmers, S., McCarron, J.G., The mitochondrial membrane potential and Ca2 + oscillations in smooth muscle. J. Cell Sci. 121 (2008), 75–85.
8. Chaplin, N.L., Nieves-Cintron, M., Fresquez, A.M., Navedo, M.F., Amberg, G.C., Arterial smooth muscle mitochondria amplify hydrogen peroxide microdomains functionally coupled to L-type calcium channels. Circ. Res. 117 (2015), 1013–1023.
9. Chen, Q., Vazquez, E.J., Moghaddas, S., Hoppel, C.L., Lesnefsky, E.J., Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278 (2003), 36027–36031.
10. Cho, J.H., Balasubramanyam, M., Chernaya, G., Gardner, J.P., Aviv, A., Reeves, J.P., Dargis, P.G., Christian, E.P., Oligomycin inhibits store-operated channels by a mechanism independent of its effects on mitochondrial ATP. Biochem. J. 324 (1997), 971–980.
11. Cotgreave, I.A., Sandy, M.S., Berggren, M., Moldeus, P.W., Smith, M.T., N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes. Biochem. Pharmacol. 36 (1987), 2899–2904.
12. Daunt, M., Dale, O., Smith, P.A., Somatostatin inhibits oxidative respiration in pancreatic beta-cells. Endocrinology 147 (2006), 1527–1535.
13. Dong, L., Xie, M.J., Zhang, P., Ji, L.L., Liu, W.C., Dong, M.Q., Gao, F., Rotenone partially reverses decreased BK Ca currents in cerebral artery smooth muscle cells from streptozotocin-induced diabetic mice. Clin. Exp. Pharmacol. Physiol. 36 (2009), e57–e64.
14. Drose, S., Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotection and pre- and postconditioning. Biochim. Biophys. Acta 1827 (2013), 578–587.
15. Dupuis, J., Tardif, J.C., Cernacek, P., Theroux, P., Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 99 (1999), 3227–3233.
16. El-Mir, M.Y., Nogueira, V., Fontaine, E., Averet, N., Rigoulet, M., Leverve, X., Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275 (2000), 223–228.
17. Engholm, M., Pinilla, E., Mogensen, S., Matchkov, V., Hedegaard, E.R., Chen, H., Mulvany, M.J., Simonsen, U., Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries. Br. J. Pharmacol. 173 (2016), 839–855.
18. Fearon, I.M., OxLDL enhances L-type Ca2 + currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production. Cardiovasc. Res. 69 (2006), 855–864.
19. Frezza, C., Cipolat, S., Scorrano, L., Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2 (2007), 287–295.
20. Gao, Q., Wolin, M.S., Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H978–H989.
21. Gao, Q., Zhao, X., Ahmad, M., Wolin, M.S., Mitochondrial-derived hydrogen peroxide inhibits relaxation of bovine coronary arterial smooth muscle to hypoxia through stimulation of ERK MAP kinase. Am. J. Physiol. 297 (2009), H2262–H2269.
22. Ghaffari, N., Ball, C., Kennedy, J.A., Stafford, I., Beltrame, J.F., Acute modulation of vasoconstrictor responses by pravastatin in small vessels. Circ. J. 75 (2011), 1506–1514.
23. Gilbert, G., Ducret, T., Marthan, R., Savineau, J.P., Quignard, J.F., Stretch-induced Ca2 + signalling in vascular smooth muscle cells depends on Ca2 + store segregation. Cardiovasc. Res. 103 (2014), 313–323.
24. Hashitani, H., Lang, R.J., Mitsui, R., Mabuchi, Y., Suzuki, H., Distinct effects of CGRP on typical and atypical smooth muscle cells involved in generating spontaneous contractions in the mouse renal pelvis. Br. J. Pharmacol. 158 (2009), 2030–2045.
25. Hedegaard, E.R., Gouliaev, A., Winther, A.K., Arcanjo, D.D., Aalling, M., Renaltan, N.S., Wood, M.E., Whiteman, M., Skovgaard, N., Simonsen, U., Involvement of potassium channels and calcium-independent mechanisms in hydrogen sulfide-induced relaxation of rat mesenteric small arteries. J. Pharmacol. Exp. Ther. 356 (2016), 53–63.
26. Jones, S.P., Teshima, Y., Akao, M., Marban, E., Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes. Circ. Res. 93 (2003), 697–699.
27. Joshi, H.N., Fakes, M.G., Serajuddin, A.T.M., Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors by their relative lipophilicity. Pharm. Pharmacol. Commun. 5 (1999), 269–271.
28. Kang, S., Woo, H.H., Kim, K., Lim, K.M., Noh, J.Y., Lee, M.Y., Bae, Y.M., Bae, O.N., Chung, J.H., Dysfunction of vascular smooth muscle and vascular remodeling by simvastatin. Toxicol. Sci. 138 (2014), 446–556.
29. Kantola, T., Kivisto, K.T., Neuvonen, P.J., Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clin. Pharmacol. Ther. 64 (1998), 177–182.
30. Katakam, P.V., Gordon, A.O., Sure, V.N., Rutkai, I., Busija, D.W., Diversity of mitochondria-dependent dilator mechanisms in vascular smooth muscle of cerebral arteries from normal and insulin-resistant rats. Am. J. Physiol. Heart Circ. Physiol. 307 (2014), H493–H503.
31. Landolfi, B., Curci, S., Debellis, L., Pozzan, T., Hofer, A.M., Ca2 + homeostasis in the agonist-sensitive internal store: functional interactions between mitochondria and the ER measured in situ in intact cells. J. Cell Biol. 142 (1998), 1235–1243.
32. Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C.N., Bang, L.E., Bundgaard, H., Nielsen, L.B., Helge, J.W., Dela, F., Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance. J. Am. Coll. Cardiol. 61 (2013), 44–53.
33. Laufs, U., La Fata, V., Plutzky, J., Liao, J.K., Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 (1998), 1129–1135.
34. Lelliott, A., Nikkar-Esfahani, A., Offer, J., Orchard, P., Roberts, R.E., The role of extracellular-signal regulate kinase (ERK) in the regulation of airway tone in porcine isolated peripheral bronchioles. Eur. J. Pharmacol. 674 (2012), 407–414.
35. Liao, J.K., Laufs, U., Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45 (2005), 89–118.
36. Lilja, J.J., Kivisto, K.T., Neuvonen, P.J., Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin. Pharmacol. Ther. 64 (1998), 477–483.
37. + channels in the endothelium-dependent and endothelium-independent components of the relaxant effect of rosuvastatin in rat aortic rings. J. Cardiovasc. Pharmacol. Ther. 13 (2008), 207–213.
38. McCarron, J.G., Olson, M.L., Wilson, C., Sandison, M.E., Chalmers, S., Examining the role of mitochondria in Ca(2)(+) signaling in native vascular smooth muscle. Microcirculation 20 (2013), 317–329.
39. Michelakis, E.D., Hampl, V., Nsair, A., Wu, X., Harry, G., Haromy, A., Gurtu, R., Archer, S.L., Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ. Res. 90 (2002), 1307–1315.
40. Miller, A.W., Tulbert, C.D., Busija, D.W., Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004), R157–R160.
41. Mukai, Y., Shimokawa, H., Matoba, T., Hiroki, J., Kunihiro, I., Fujiki, T., Takeshita, A., Acute vasodilator effects of HMG-CoA reductase inhibitors: involvement of PI3-kinase/Akt pathway and Kv channels. J. Cardiovasc. Pharmacol. 42 (2003), 118–124.
42. Muraki, A., Miyashita, K., Mitsuishi, M., Tamaki, M., Tanaka, K., Itoh, H., Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance. J. Appl. Physiol. 113 (2012), 479–486.
43. Nadanaciva, S., Bernal, A., Aggeler, R., Capaldi, R., Will, Y., Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol. in Vitro 21 (2007), 902–911.
44. Nadanaciva, S., Dykens, J.A., Bernal, A., Capaldi, R.A., Will, Y., Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. Toxicol. Appl. Pharmacol. 223 (2007), 277–287.
45. Ng, L.L., Davies, J.E., Wojcikiewicz, R.J., 3-Hydroxy-3-methyl glutaryl coenzyme A reductase inhibition modulates vasopressin-stimulated Ca2 + responses in rat A10 vascular smooth muscle cells. Circ. Res. 74 (1994), 173–181.
46. Omar, H.A., Cherry, P.D., Mortelliti, M.P., Burke-Wolin, T., Wolin, M.S., Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxations. Circ. Res. 69 (1991), 601–608.
47. Pyla, R., Osman, I., Pichavaram, P., Hansen, P., Segar, L., Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKbeta and attenuates contractile response in endothelium-denuded rat aorta. Biochem. Pharmacol. 92 (2014), 266–279.
48. Rashid, F., Horobin, R.W., Accumulation of fluorescent non-cationic probes in mitochondria of cultured cells: observations, a proposed mechanism, and some implications. J. Microsc. 163 (1991), 233–241.
49. Rossoni, L.V., Wareing, M., Wenceslau, C.F., Al-Abri, M., Cobb, C., Austin, C., Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries. Clin. Sci. 121 (2011), 449–458.
50. Scragg, J.L., Dallas, M.L., Wilkinson, J.A., Varadi, G., Peers, C., Carbon monoxide inhibits L-type Ca2 + channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species. J. Biol. Chem. 283 (2008), 24412–24419.
51. Seto, S.W., Au, A.L., Lam, T.Y., Chim, S.S., Lee, S.M., Wan, S., Tjiu, D.C., Shigemura, N., Yim, A.P., Chan, S.W., Tsui, S.K., Leung, G.P., Kwan, Y.W., Modulation by simvastatin of iberiotoxin-sensitive, Ca2 +-activated K + channels of porcine coronary artery smooth muscle cells. Br. J. Pharmacol. 151 (2007), 987–997.
52. Seto, S.W., Au, A.L., Poon, C.C., Zhang, Q., Li, R.W., Yeung, J.H., Kong, S.K., Ngai, S.M., Wan, S., Ho, H.P., Lee, S.M., Hoi, M.P., Chan, S.W., Leung, G.P., Kwan, Y.W., Acute simvastatin inhibits K ATP channels of porcine coronary artery myocytes. PLoS One, 8, 2013, e66404.
53. Sirvent, P., Mercier, J., Vassort, G., Lacampagne, A., Simvastatin triggers mitochondria-induced Ca2 + signaling alteration in skeletal muscle. Biochem. Biophys. Res. Commun. 329 (2005), 1067–1075.
54. Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., Mercier, J., Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins. Toxicol. Appl. Pharmacol. 259 (2012), 263–268.
55. Sonmez Uydes-Dogan, B., Topal, G., Takir, S., Ilkay Alp, F., Kaleli, D., Ozdemir, O., Relaxant effects of pravastatin, atorvastatin and cerivastatin on isolated rat aortic rings. Life Sci. 76 (2005), 1771–1786.
56. Tavackoli, S., Ashitkov, T., Hu, Z.Y., Motamedi, M., Uretsky, B.F., Birnbaum, Y., Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K + channels. Coron. Artery Dis. 15 (2004), 53–58.
57. Tavintharan, S., Ong, C.N., Jeyaseelan, K., Sivakumar, M., Lim, S.C., Sum, C.F., Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?. Toxicol. Appl. Pharmacol. 223 (2007), 173–179.
58. Tiefenbacher, C.P., Friedrich, S., Bleeke, T., Vahl, C., Chen, X., Niroomand, F., ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles. Am. J. Physiol. Heart Circ. Physiol. 286 (2004), H1425–H1432.
59. Uhiara, C.O., Alexander, S.P., Roberts, R.E., Simvastatin evokes an unpredicted inhibition of beta-adrenoceptor-mediated vasodilatation in porcine coronary artery. Eur. J. Pharmacol. 690 (2012), 158–163.
60. Vaughan, R.A., Garcia-Smith, R., Bisoffi, M., Conn, C.A., Trujillo, K.A., Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur. J. Pharmacol. 711 (2013), 1–9.
61. Wang, Q.S., Zheng, Y.M., Dong, L., Ho, Y.S., Guo, Z., Wang, Y.X., Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes. Free Radic. Biol. Med. 42 (2007), 642–653.
62. Weir, E.K., Olschewski, A., Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia. Cardiovasc. Res. 71 (2006), 630–641.
63. Wu, P.Y., Lai, B., Dong, Y., Wang, Z.M., Li, Z.C., Zheng, P., Different oxidants and PKC isozymes mediate the opposite effect of inhibition of Q(i) and Q(o) site of mitochondrial complex III on calcium currents in rat cortical neurons. Biochim. Biophys. Acta 1803 (2010), 1072–1082.
64. Xi, Q., Cheranov, S.Y., Jaggar, J.H., Mitochondria-derived reactive oxygen species dilate cerebral arteries by activating Ca2 + sparks. Circ. Res. 97 (2005), 354–362.
65. Yang, Y.J., Zhao, J.L., You, S.J., Wu, Y.J., Jing, Z.C., Gao, R.L., Chen, Z.J., Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel. Eur. J. Heart Fail. 9 (2007), 30–36.
66. Zhang, W., Wu, J., Zhou, L., Xie, H.Y., Zheng, S.S., Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J. Exp. Biol. 48 (2010), 1167–1174.
67. Zhao, J.L., Yang, Y.J., Cui, C.J., You, S.J., Gao, R.L., Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel. Br. J. Pharmacol. 149 (2006), 243–249.